[Diagnosis of malignant pleural mesothelioma and asbestosis].
The incidence of malignant mesothelioma, the main consequence of exposure to asbestos, will increase considerably in the Netherlands in the coming decades. In the next 35 year, some 20,000 people will die from malignant mesothelioma. The diagnosis of malignant pleural mesothelioma in practice is based on histological examination in about 80%, on cytological examination in 15% and on other forms of examination, e.g., high resolution computer tomography (HRCT), in 6% of the cases. Using a combination of various noninvasive methods, such as anamnesis, physical and röntgenologic examination, HRCT and spirometry, the diagnosis of asbestosis is made erroneously in 5% of the patients examined. With regard to allowance of financial compensation to patients with pleural mesothelioma and asbestosis, a part is played by the fact that views differ internationally concerning the criteria on which the diagnosis should be based. For mesothelioma cytologic and histologic examination are the most important. For asbestosis, the Health Council considers HRCT as crucial, if necessary supplemented by histological examination, plus a history of exposure to asbestos and pulmonary dysfunction. In mesothelioma cytological and histological examination are the most important.
Schermer
T R
TR
Katholieke Universiteit, afd. Huisartsgeneeskunde, Sociale Geneeskunde en Verpleeghuisgeneeskunde, Nijmegen. t.schermer@hsv.kun.nl
Cox
A L
AL
D001195:Asbestosis / Q000150:complications / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology; D004608:Eligibility Determination / Q000592:standards*; D014943:Global Health; D006801:Humans; D008654:Mesothelioma / Q000150:complications / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology; D009426:Netherlands / Q000453:epidemiology; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology / Q000209:etiology; D014942:Workers' Compensation / Q000191:economics / Q000592:standards*
Diagnostiek van maligne pleuramesothelioom en asbestose.